AP1M1

AP-1 complex subunit mu-1 · Q9BXS5 · AP1M1 on Sugi Atlas →

0 patent compounds predicted against AP1M1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to AP1M1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients PHASE4NOT_YET_RECRUITING
Clinical Evaluation of the Effect of Metformin in Sepsis PHASE3UNKNOWN
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room PHASE2/PHASE3COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma PHASE1/PHASE2SUSPENDED
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations PHASE2RECRUITING
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck PHASE1WITHDRAWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Phase I Study of APX005M in Pediatric Central Nervous System Tumors PHASE1ACTIVE_NOT_RECRUITING
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Pigeon Peas (Cajanus Cajan) : a Natural Anti-inflammatory Facilitating Weight Loss in Obese Patients Returning to Sport? nanUNKNOWN
Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure nanUNKNOWN
Identification of Acute Intermittent Porphyria Modifying Genes nanRECRUITING
High Altitude Medical Research Expedition Himlung 2013 - a Study of Human Adaption to Hypoxia nanCOMPLETED
Identification and Characterization of Monogenic Diabetes nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED
Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a AP1M1 binder may also engage these)

ProteinNameSimilarity
Q2KJ81 1.000 Q2KJ81 →
Q32Q06 0.998 Q32Q06 →
P35585 0.997 P35585 →
F1QGW6 0.940 F1QGW6 →
Q5R797 0.939 Q5R797 →
Q5ZMS3 0.938 Q5ZMS3 →
Q2KHU8 0.937 Q2KHU8 →
Q2VIR3 0.936 Q2VIR3 →
P81795 0.934 P81795 →
Q3SYW1 0.934 Q3SYW1 →
P20461 0.933 P20461 →
Q2YDH6 0.932 Q2YDH6 →
Q9DCR2 0.931 Q9DCR2 →
P41091 0.931 P41091 →
Q9Z0N1 0.930 Q9Z0N1 →
AP3S1 AP-3 complex subunit sigma-1 0.930 landscape →
C9WPN6 0.929 C9WPN6 →
P23330 0.928 P23330 →
Q9WVP1 0.927 Q9WVP1 →
Q9Y6Q5 0.927 Q9Y6Q5 →
Q9Z0N2 0.926 Q9Z0N2 →
Q32KM1 0.922 Q32KM1 →
D3ZRP6 0.919 D3ZRP6 →
Q9GKK5 0.919 Q9GKK5 →
Q9NRH3 0.918 Q9NRH3 →
P63073 0.918 P63073 →
Q0VCD2 0.917 Q0VCD2 →
O54984 0.916 O54984 →
Q6NVL5 0.916 Q6NVL5 →
P83888 0.916 P83888 →